Royal Philips
3
20M
3
0.02
1
- Areas of investment
Summary
The main office of represented Corporate Investor is situated in the Amsterdam. The company was established in Europe in The Netherlands.
The usual things for fund are deals in the range of 5 - 10 millions dollars. The high activity for fund was in 2018. The fund is constantly included in less than 2 deals per year.
The standard case for the fund is to invest in rounds with 6 partakers. The meaningful sponsors for the fund in investment in the same round are Waterline Ventures, Sanofi-Genzyme BioVentures, Qualcomm Ventures.
Among the most popular portfolio startups of the fund, we may highlight Common Sensing. Among the most popular fund investment industries, there are Software, Manufacturing. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.02
- Investments by industry
- Biotechnology (2)
- Product Design (1)
- Manufacturing (1)
- Health Diagnostics (1)
- Medical Device (1) Show 3 more
- Investments by region
-
- Switzerland (1)
- United States (1)
- The Netherlands (1)
- Peak activity year
- 2007
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 18
- Avg. valuation at time of investment
- 177M
- Group Appearance index
- 1.00
- Strategy success index
- 0.38
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Kereos | 20 Sep 2005 | Biotechnology, Health Care, Life Science, Therapeutics | Early Stage Venture | 19M | United States, Missouri, City of Saint Louis |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.